Jefferies Financial Group Inc. Denali Therapeutics Inc. Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$15.83 - $23.35 $1.52 Million - $2.24 Million	-96,013 Reduced 58.07%	69,314 $1.42 Million
Q4 2023 Feb 13, 2024	BUY	$16.2 - $23.18 $2.47 Million - $3.54 Million	152,527 Added 1191.62%	165,327 $3.55 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $264,064 - $386,176	12,800 New	12,800 $264,000
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $5.77 Million - $8.6 Million	263,123 New	263,123 $6.06 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.